These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2919489)

  • 21. [Bilateral testicular metastasis of an adenocarcinoma of the prostate].
    Giannakopoulos X; Bai M; Grammeniatis E; Stefanou D; Agnanti N
    Ann Urol (Paris); 1994; 28(5):274-6. PubMed ID: 7825987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular changes in prostatic carcinoma after treatment with orchidectomy, estramustine phosphate and medroxyprogesterone acetate.
    Tomic R; Angström T; Ljungberg B
    Scand J Urol Nephrol; 1997 Jun; 31(3):255-8. PubMed ID: 9249888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
    Zincke H; Utz DC; Taylor WF
    J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoma of the prostate: reasons for endocrine treatment prior to symptomatic metastases.
    Chisholm GD
    Prog Clin Biol Res; 1990; 359():1-6; discussion 15-24. PubMed ID: 2284285
    [No Abstract]   [Full Text] [Related]  

  • 25. French multicenter study on the use of estramustine phosphate versus diethylstilbestrol.
    Hauchecorne J
    Prog Clin Biol Res; 1987; 243B():229-34. PubMed ID: 3309983
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of metastatic prostatic cancer.
    Paulson DF
    Urology; 1985 Feb; 25(2 Suppl):49-52. PubMed ID: 3918376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Solitary cerebral metastasis of endometrial carcinoma. A case report].
    Crispino M; Tira A; Volpi D; Olivetti L
    Radiol Med; 2000 Dec; 100(6):515-7. PubMed ID: 11307521
    [No Abstract]   [Full Text] [Related]  

  • 28. Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    JAMA; 1977 Jun; 237(23):2471. PubMed ID: 576957
    [No Abstract]   [Full Text] [Related]  

  • 29. Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer Group.
    Iversen P; Rasmussen F; Asmussen C; Christensen IJ; Eickhoff J; Klarskov P; Larsen E; Mogensen P; Mommsen S; Rosenkilde P
    J Urol; 1997 Mar; 157(3):929-34. PubMed ID: 9072602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cerebral metastasis from prostatic neoplasm simulating meningioma. Report of a case].
    Oliveira MA; Araujo JF; Balbo RJ
    Arq Neuropsiquiatr; 1993 Jun; 51(2):251-2. PubMed ID: 8274090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain metastasis from prostate cancer: a case report.
    Zhang X; Tsukuda F; Yamamoto N; Takenaka I
    Int J Urol; 1997 Sep; 4(5):519-21. PubMed ID: 9354958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate.
    Morales A; Nickel JC
    Urology; 1985 Nov; 26(5):477-81. PubMed ID: 3904134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Histological effects of hormono-chemotherapy on prostatic cancer].
    Matsushima H; Fujita K; Ueki T; Munakata A; Yamazaki S
    Nihon Hinyokika Gakkai Zasshi; 1991 Sep; 82(9):1473-9. PubMed ID: 1719264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system metastasis from gallbladder carcinoma--case report.
    Takano S; Yoshii Y; Owada T; Shirai S; Nose T
    Neurol Med Chir (Tokyo); 1991 Dec; 31(12):782-6. PubMed ID: 1726227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of clinically localized prostatic cancer--endocrine therapy].
    Hirano A
    Hinyokika Kiyo; 1996 Oct; 42(10):829-32. PubMed ID: 8951483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical course of hormone refractory cancer of the prostate].
    Morote J; Vila J; López-Pacios MA; De Torres JA; Soler-Roselló A
    Actas Urol Esp; 1992 Oct; 16(9):722-5. PubMed ID: 1283286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of orbital metastasis from prostatic carcinoma as an initial symptom.
    Isshiki S; Cho S; Matsuno D; Sato N; Furuya Y
    Hinyokika Kiyo; 2007 Mar; 53(3):193-5. PubMed ID: 17447492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined hormone-chemotherapy for metastatic prostatic carcinoma. Eleven-year follow-up.
    Servadio C; Savion M; Mukamel E
    Urology; 1987 Oct; 30(4):352-5. PubMed ID: 3660524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
    Flamm J; Fischer M
    Wien Klin Wochenschr; 1988 Sep; 100(17):589-92. PubMed ID: 3055689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.